PH21591A - Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition - Google Patents

Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition

Info

Publication number
PH21591A
PH21591A PH33167A PH33167A PH21591A PH 21591 A PH21591 A PH 21591A PH 33167 A PH33167 A PH 33167A PH 33167 A PH33167 A PH 33167A PH 21591 A PH21591 A PH 21591A
Authority
PH
Philippines
Prior art keywords
pharmaceutical composition
acid
active ingredient
composition containing
cis vitamin
Prior art date
Application number
PH33167A
Other languages
English (en)
Inventor
Paul B Jarosz
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of PH21591A publication Critical patent/PH21591A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH33167A 1984-12-14 1985-12-12 Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition PH21591A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68197084A 1984-12-14 1984-12-14

Publications (1)

Publication Number Publication Date
PH21591A true PH21591A (en) 1987-12-11

Family

ID=24737639

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33167A PH21591A (en) 1984-12-14 1985-12-12 Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition

Country Status (9)

Country Link
EP (1) EP0184942B1 (xx)
JP (1) JPS61145114A (xx)
AT (1) ATE55247T1 (xx)
AU (1) AU583568B2 (xx)
CA (1) CA1282326C (xx)
DE (1) DE3579128D1 (xx)
DK (1) DK581185A (xx)
GR (1) GR852997B (xx)
PH (1) PH21591A (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
US5175002A (en) * 1991-10-02 1992-12-29 Du Pont Merck Pharmaceutical Company Amantadine hydrochloride syspension with enhanced dissolution characteristics for use in soft gelatin capsules
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US5962522A (en) * 1997-09-05 1999-10-05 Avmax, Inc. Propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
US6180666B1 (en) 1997-09-05 2001-01-30 Anmax, Inc. Use of gallic acid esters to increase bioavailability of orally administered pharmaceutical compounds
PE20001227A1 (es) * 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US7374779B2 (en) 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6733779B2 (en) * 1999-08-26 2004-05-11 L. Dean Parks Method of treating benign prostatic hyperplasia and other benign prostate conditions
FR2807662A1 (fr) * 2000-04-12 2001-10-19 Cll Pharma Procede pour stabiliser la granulometrie d'un principe actif verulent disperse dans un liquide et ses applications
IN192188B (xx) * 2000-06-16 2004-03-13 Ranbaxy Lab Ltd
DE60104206T2 (de) 2000-09-22 2005-09-22 Galephar M/F Halbfeste arzneizubereitung enthaltend isotretinoin
MXPA04005497A (es) * 2001-12-06 2004-10-11 Ranbaxy Lab Ltd Composiciones nanoparticuladas de isotretinoin.
EP1527774A1 (en) * 2003-11-03 2005-05-04 Basilea Pharmaceutica AG New formulation for retinoid-containing soft gelatin capsules
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
WO2010109259A1 (es) * 2009-03-26 2010-09-30 Grufarcol Ltda Métoda para preparar formulaciones de gel blando de isotretinoína líquida y la formulaciones obtenidas
MX2011012233A (es) 2009-05-20 2012-04-19 Ranbaxy Lab Ltd Soluciones de retinoide topicas.
US10022348B2 (en) 2009-05-20 2018-07-17 Sun Pharmaceutical Industries Limited Topical solution of isotretinoin
BRPI1010970A2 (pt) 2009-05-20 2019-04-09 Ranbaxy Laboratories Limited solução farmacêutica, processo para preparar uma solução farmacêutica e método para tratamento
KR101710505B1 (ko) 2009-09-15 2017-02-27 노벨리언 테라퓨틱스 인코포레이티드 리피드 비히클에 9-시스-레티닐 에스테르를 포함하는 약제 처방
WO2011047259A1 (en) 2009-10-16 2011-04-21 Glaxosmithkline Llc Compositions
RU2622763C2 (ru) 2010-04-19 2017-06-19 Новелион Терапьютикс Инк. Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
BR112014021602A2 (pt) 2012-03-01 2021-06-08 Quadra Logic Tech Inc uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide
US9078925B2 (en) 2012-06-18 2015-07-14 Galephar Pharmaceutical Research, Inc. Pharmaceutical semi-solid composition of isotretinoin
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. ORAL TESTOSTERONE UNDECANOATE THERAPY
WO2019205030A1 (zh) * 2018-04-25 2019-10-31 人福普克药业（武汉）有限公司 盐酸金刚烷胺软胶囊及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124510A (en) * 1964-03-10 Stable dry powdered fat-soluble
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
GB1590864A (en) * 1978-05-16 1981-06-10 Lilly Industries Ltd Thixotropic filling medium for hard gelatin capsules
US4322438A (en) * 1979-08-06 1982-03-30 United States Of America Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
JPH0244806B2 (ja) * 1981-09-07 1990-10-05 Sunstar Kk Bitaminaoanteinihaigoshitanyukakeihifugaiyozaisoseibutsu
CH658387A5 (de) * 1984-04-02 1986-11-14 Hoffmann La Roche Pharmazeutische praeparate.

Also Published As

Publication number Publication date
DK581185D0 (da) 1985-12-13
AU5122685A (en) 1986-07-17
ATE55247T1 (de) 1990-08-15
AU583568B2 (en) 1989-05-04
JPS61145114A (ja) 1986-07-02
GR852997B (xx) 1986-04-16
CA1282326C (en) 1991-04-02
EP0184942B1 (en) 1990-08-08
EP0184942A2 (en) 1986-06-18
DE3579128D1 (de) 1990-09-13
DK581185A (da) 1986-06-15
EP0184942A3 (en) 1987-08-05

Similar Documents

Publication Publication Date Title
PH21591A (en) Improved pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient and method of using said pharmaceutical composition
HUT47274A (en) Process for producing terciary hydroxy-alkyl-xantines and pharmaceutical compositions containing them as active components
HUT47576A (en) Process for production of 2-amin-purin-derivatives and medical compositions containing them as active substance
AU8040487A (en) Substituted alpha-amino acids, their preparation and pharmaceutical compositions containing them
IL76133A (en) Mercaptomethyl-octahydro-oxo-pyridazino(1,2-a)(1,2)diazepine-,diazocine-and(1,2,5)triazepinecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them and certain intermediates therefor
HUT41800A (en) Process for producing new beta-lactame antibiotica and pharmaceutical compositions containing them as active agents
HUT37745A (en) Pesticide, first of all insecticide compositions containing substituted malonic acid derivatives as active agents and process for producing substituted malonic acid derivatives
EP0215596A3 (en) Composition for injection of active type vitamins d3
IL74734A0 (en) Substituted alpha-amino acids,their preparation and pharmaceutical compositions containing them
HK93687A (en) The use of salicyclic acid esters as perfumes,perfume compositions containing them and new salicyclic esters
GB2191483B (en) New retinoic acid esters of antibiotics , process for the preparation thereof and pharmaceutical and cosmetic compositions containing them
HUT41750A (en) Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT51284A (en) Process for production of epipodofillotoxin glucozides substituated by fluor and medical compositions containing them as active substance
IL65922A (en) Preparation of apovincaminic acid esters,certain novel optically active trans-derivatives thereof and pharmaceutical compositions containing them
ES8705434A1 (es) Procedimiento para la preparacion de derivados de acido 4-(isoxazolil)-tiazol-2-oxamico
IL79181A0 (en) 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof,their preparation and pharmaceutical compositions containing them
HUT44129A (en) Herbicide compositions containing 1-aryl-pyrazol derivatives as active components and process for producing 1-aryl-pyrazol derivatives
PH21875A (en) Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient
PH21556A (en) Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof
HUT41211A (en) Insecticide compositions containing alkane derivatives as active substances and process for preparing the active ingredients
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
HUT49145A (en) Process for production of 14,15 substituated ianosterins and medical compositions containing them as active substance
HUT37785A (en) Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents
HUT39978A (en) Pesticide compositions containing pyrimidinyl-thiono-phosphoric acid derivatives as active substabces and process for preparing pyrimidinyl-thiono-phosphoric acid derivatives